The Technical AnalystExchange: HKSE Industry: Capital Goods
Meilleure Health Price, Forecast, Insider, Ratings, Fundamentals & Signals
1.97% HKD0.155
America/New_York / 3 mai 2024 @ 03:38
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 634.53 mill |
| EPS: | 0.0100 |
| P/E: | 15.50 |
| Earnings Date: | Mar 28, 2024 |
| SharesOutstanding: | 4 093.76 mill |
| Avg Daily Volume: | 2.75 mill |
| RATING 2024-05-03 |
|---|
| B- |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Neutral | |
| Return On Asset: | Buy | |
| DE: | Neutral | |
| P/E: | Sell | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/21 | 4/21 | 2/22 | 4/22 | 2/23 | 4/23 | |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Gr.Profit | n/a | n/a | n/a | n/a | n/a | n/a |
| Ebit | n/a | n/a | n/a | n/a | n/a | n/a |
| Asset | n/a | n/a | n/a | n/a | n/a | n/a |
| Debt | n/a | n/a | n/a | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.93x |
| Company: PE 15.50 | sector: PE 16.62 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 1.19x |
| Company: PE 15.50 | industry: PE 13.03 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
HKD-0.106 (-168.08%) HKD-0.261 |
| Date: 2024-05-03 |
| Expected Trading Range (DAY) |
|---|
|
HKD 0.136 - 0.174 ( +/- 12.26%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 |
| Volume Signals | |
|---|---|
| Price | HKD0.155 (1.97% ) |
| Volume | 1.440 mill |
| Avg. Vol. | 2.75 mill |
| % of Avg. Vol | 52.40 % |
| Signal 1: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For 2327.HK
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
2327.HK
Meilleure Health International Industry Group Limited, an investment holding company, engages in industrial hemp, healthcare-related, trading, agency service, property investment and leasing, and property development businesses in Hong Kong, the People's Republic of China, and internationally. The company is involved in the trading of construction materials; development and sale of residential properties; property investment and leasing activities; and sale of healthcare-related products. It also provides real estate agency services; cannabidiol downstream product application services; health management services, including anti-aging, aesthetic medicine, and other health consulting; and healthcare related product sales agency services. The company was formerly known as U-Home Group Holdings Limited and changed its name to Meilleure Health International Industry Group Limited in March 2017. Meilleure Health International Industry Group Limited is headquartered in Admiralty, Hong Kong.